Condition: Asthma · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the year prior to enrollment and cannot demonstrate bronchodilator reversibility at baseline. Phenotypic characteristics will be established at baseline, and the participants will be seen at scheduled visits over 12 months. Each participant will be asked to monitor and self-report cold symptoms and will be asked to complete up to three cold visits
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Children's Hospital Colorado: Allergy Program | Aurora, Colorado, United States | Recruiting |
| Children's National Medical Center: Children's Research Institute | Washington D.C., District of Columbia, United States | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology | Chicago, Illinois, United States | Recruiting |
| Boston University School of Medicine: Pulmonary Center | Boston, Massachusetts, United States | Recruiting |
| Boston Children's Hospital: Department of Immunology | Boston, Massachusetts, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute | New York, New York, United States | Recruiting |
| Columbia University Medical Center: Division of Pediatric Pulmonology | New York, New York, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center: Asthma Center | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06136091